219 related articles for article (PubMed ID: 21852337)
21. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
Nardi-Agmon I; Abud-Hawa M; Liran O; Gai-Mor N; Ilouze M; Onn A; Bar J; Shlomi D; Haick H; Peled N
J Thorac Oncol; 2016 Jun; 11(6):827-37. PubMed ID: 26968885
[TBL] [Abstract][Full Text] [Related]
22. Study of the art: canine olfaction used for cancer detection on the basis of breath odour. Perspectives and limitations.
Jezierski T; Walczak M; Ligor T; Rudnicka J; Buszewski B
J Breath Res; 2015 May; 9(2):027001. PubMed ID: 25944810
[TBL] [Abstract][Full Text] [Related]
23. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
24. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
25. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
[TBL] [Abstract][Full Text] [Related]
27. Detection of lung cancer with electronic nose and logistic regression analysis.
Tirzïte M; Bukovskis M; Strazda G; Jurka N; Taivans I
J Breath Res; 2018 Nov; 13(1):016006. PubMed ID: 30221629
[TBL] [Abstract][Full Text] [Related]
28. Exhaled breath analysis for lung cancer detection using ion mobility spectrometry.
Handa H; Usuba A; Maddula S; Baumbach JI; Mineshita M; Miyazawa T
PLoS One; 2014; 9(12):e114555. PubMed ID: 25490772
[TBL] [Abstract][Full Text] [Related]
29. VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials.
Biehl W; Hattesohl A; Jörres RA; Duell T; Althöhn U; Koczulla AR; Schmetzer H
Acta Oncol; 2019 Sep; 58(9):1216-1224. PubMed ID: 31311375
[No Abstract] [Full Text] [Related]
30. Lung cancer diagnosis by trained dogs.
Guirao Montes Á; Molins López-Rodó L; Ramón Rodríguez I; Sunyer Dequigiovanni G; Viñolas Segarra N; Marrades Sicart RM; Hernández Ferrández J; Fibla Alfara JJ; Agustí García-Navarro Á
Eur J Cardiothorac Surg; 2017 Dec; 52(6):1206-1210. PubMed ID: 28977566
[TBL] [Abstract][Full Text] [Related]
31. Sniffer dogs can identify lung cancer patients from breath and urine samples.
Feil C; Staib F; Berger MR; Stein T; Schmidtmann I; Forster A; Schimanski CC
BMC Cancer; 2021 Aug; 21(1):917. PubMed ID: 34388977
[TBL] [Abstract][Full Text] [Related]
32. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
33. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
34. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
35. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
[TBL] [Abstract][Full Text] [Related]
36. Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer.
de Castro J; Rodríguez MC; Martínez-Zorzano VS; Sánchez-Rodríguez P; Sánchez-Yagüe J
Am J Clin Pathol; 2014 Jul; 142(1):111-20. PubMed ID: 24926094
[TBL] [Abstract][Full Text] [Related]
37. [Measurement of exhaled volatile organic compounds in lung cancer patients].
Lu CR; Hu YJ; Chen EG; Qiu YH; Ying KJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):104-8. PubMed ID: 20367949
[TBL] [Abstract][Full Text] [Related]
38. Diagnosing COPD and targeted lung cancer screening.
Young RP; Hopkins RJ
Eur Respir J; 2012 Oct; 40(4):1063-4. PubMed ID: 23024333
[No Abstract] [Full Text] [Related]
39. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
40. [Please puff once! Is it possible to diagnose cancer by smell?].
Schipper J
MMW Fortschr Med; 2009 Dec; 151(49-50):6. PubMed ID: 20085067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
